Esperion Therapeutics, Inc. (ESPR)

Esperion Therapeutics Statistics

Total Valuation

ESPR has a market cap or net worth of $185.98 million. The enterprise value is $634.25 million.

Market Cap	185.98M
Enterprise Value	634.25M

Important Dates

The next confirmed earnings date is Tuesday, May 6, 2025, before market open.

Earnings Date	May 6, 2025
Ex-Dividend Date	n/a

Share Statistics

ESPR has 197.85 million shares outstanding. The number of shares has increased by 81.54% in one year.

Current Share Class	197.85M
Shares Outstanding	197.85M
Shares Change (YoY)	+81.54%
Shares Change (QoQ)	+0.33%
Owned by Insiders (%)	1.11%
Owned by Institutions (%)	59.76%
Float	195.66M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.53
Forward PS	0.52
PB Ratio	-0.48
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	1.91
EV / EBITDA	11.65
EV / EBIT	11.66
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.37

Current Ratio	1.37
Quick Ratio	0.91
Debt / Equity	n/a
Debt / EBITDA	10.29
Debt / FCF	n/a
Interest Coverage	0.92

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	12.37%
Return on Invested Capital (ROIC)	23.58%
Return on Capital Employed (ROCE)	55.75%
Revenue Per Employee	$1.09M
Profits Per Employee	-$170,214
Employee Count	304
Asset Turnover	1.21
Inventory Turnover	1.43

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -50.79% in the last 52 weeks. The beta is 0.86, so ESPR's price volatility has been lower than the market average.

Beta (5Y)	0.86
52-Week Price Change	-50.79%
50-Day Moving Average	1.49
200-Day Moving Average	1.98
Relative Strength Index (RSI)	29.83
Average Volume (20 Days)	5,624,305

Short Selling Information

The latest short interest is 28.02 million, so 14.16% of the outstanding shares have been sold short.

Short Interest	28.02M
Short Previous Month	28.90M
Short % of Shares Out	14.16%
Short % of Float	14.32%
Short Ratio (days to cover)	6.23

Income Statement

In the last 12 months, ESPR had revenue of $332.31 million and -$51.75 million in losses. Loss per share was -$0.28.

Revenue	332.31M
Gross Profit	217.48M
Operating Income	54.40M
Pretax Income	n/a
Net Income	-51.75M
EBITDA	54.47M
EBIT	54.40M
Loss Per Share	-$0.28

Balance Sheet

The company has $144.76 million in cash and $591.21 million in debt, giving a net cash position of -$446.45 million or -$2.26 per share.

Cash & Cash Equivalents	144.76M
Total Debt	591.21M
Net Cash	-446.45M
Net Cash Per Share	-$2.26
Equity (Book Value)	-388.72M
Book Value Per Share	-1.98
Working Capital	91.77M

Cash Flow

In the last 12 months, operating cash flow was -$23.65 million and capital expenditures -$317,000, giving a free cash flow of -$23.97 million.

Operating Cash Flow	-23.65M
Capital Expenditures	-317,000
Free Cash Flow	-23.97M
FCF Per Share	-$0.12

Margins

Gross margin is 65.44%, with operating and profit margins of 16.37% and -15.57%.

Gross Margin	65.44%
Operating Margin	16.37%
Pretax Margin	-15.57%
Profit Margin	-15.57%
EBITDA Margin	16.39%
EBIT Margin	16.37%
FCF Margin	n/a

Dividends & Yields

ESPR does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-81.54%
Shareholder Yield	-81.54%
Earnings Yield	-27.55%
FCF Yield	-12.76%

Analyst Forecast

The average price target for ESPR is $6.07, which is 545.75% higher than the current price. The consensus rating is "Buy".

Price Target	$6.07
Price Target Difference	545.75%
Analyst Consensus	Buy
Analyst Count	7
Revenue Growth Forecast (5Y)	28.03%
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ESPR has an Altman Z-Score of -4.36 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-4.36
Piotroski F-Score	6